International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8084822
Original Article
Study on Hematological Profile in HIV Patients and its Correlation with who Clinical Staging
 ,
 ,
 ,
 ,
Published
June 27, 2023
Abstract

Introduction: A spectrum of hematological manifestations are seen at every stage of human immunodeficiency virus (HIV) infection, and they often pose a great challenge in the Diagnosis and management.

Out of all complications, Hematological abnormalities, Anemia is the most common abnormality seen in HIV s patients and its incidence is strongly associated with the progression of the disease.

Objectives: The present study aims to study the hematological manifestation in newly detected HIV patients & to study the relationship between various haematological manifestation with WHO clinical staging.

Methodology: It is a observational and descriptive study done at ART CENTRE VIMS, BALLARI, with a sample size of 108 cases. Patients who filled the inclusion criteria are assessed as per proforma specially designed for study.

Conclusion: The study concluded that anaemia was the most common haematological abnormality followed by elevated ESR, thrombocytopenia, leucopenia. CD4 count is the best predictor of WHO staging.

Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
2667 Views
117 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved